---
title: "Zhongheng Group: Wholly-owned subsidiary Zhongheng Innovation acquires a drug technology for treating chronic heart failure for 55 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/251433078.md"
description: "Zhongheng Group announced that its wholly-owned subsidiary Zhongheng Innovation has acquired a technology for treating chronic heart failure from China Rongtong Scientific Research Institute Group Co., Ltd. through a transfer method, with a transaction price of RMB 55 million. This transaction does not constitute a related party transaction and does not constitute a major asset reorganization. This transaction has been approved by the 29th meeting of the 10th Board of Directors of the company and does not require submission to the shareholders' meeting for approval"
datetime: "2025-08-04T10:35:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/251433078.md)
  - [en](https://longbridge.com/en/news/251433078.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/251433078.md)
---

# Zhongheng Group: Wholly-owned subsidiary Zhongheng Innovation acquires a drug technology for treating chronic heart failure for 55 million yuan

Zhongheng Group announced that its wholly-owned subsidiary Zhongheng Innovation has acquired a technology for treating chronic heart failure from China Rongtong Scientific Research Institute Group Co., Ltd. through a transfer method, with a transaction price of RMB 55 million. This transaction does not constitute a related party transaction and does not constitute a major asset reorganization. This transaction has been approved by the 29th meeting of the 10th Board of Directors of the company and does not require submission for shareholder meeting approval

### Related Stocks

- [600252.CN](https://longbridge.com/en/quote/600252.CN.md)

## Related News & Research

- [China Telecom's Shares Rise After Becoming Last of Country's Big Three Telcos to Roll Out Token Plans](https://longbridge.com/en/news/286859736.md)
- [Lycra Company Says To Successfully Complete Comprehensive Financial Restructuring](https://longbridge.com/en/news/286992700.md)
- [China's Bio-Thera Gets US Nod for Golimumab Biosimilar](https://longbridge.com/en/news/286880573.md)
- [Pineapple Family Launches Platform for Independent Surrogacy and Egg Donation Journeys](https://longbridge.com/en/news/287137575.md)
- [Chinese national charged in alleged scheme to smuggle drug shipments to US-SCMP](https://longbridge.com/en/news/287136583.md)